{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:25:29Z","timestamp":1794327929775,"version":"4.9.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In Argentina, widespread 13-valent pneumococcal conjugate vaccine (PCV13) use has reshaped pediatric invasive pneumococcal disease (IPD) epidemiology, with ongoing serotype shifts. We assessed IPD burden, clinical and microbiological features, PCV20 coverage, and mortality risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Multicenter prospective observational study based on active surveillance, conducted in 6 pediatric sentinel hospitals (October 2022\u2013September 2025). Children \u226415 years hospitalized with laboratory-confirmed IPD were included. Hospitalization rates per 10,000 discharges were calculated with 95% confidence intervals (CIs). Mortality risk factors were assessed using logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 136,018 hospital discharges, 218 IPD cases were identified (16.0 per 10,000; 95% CI, 14.0\u201318.3; 0.16% of hospitalizations), with the highest rates in children 2\u20134 years old (26.5 per 10,000; 95% CI: 20.6\u201333.5). Half (45.9%) had underlying conditions. Pneumonia predominated (65.6%), often complicated by pleural effusion\/empyema or necrotizing disease, and 18.9% required mechanical ventilation; meningitis occurred in 14.7%. Among 119 serotyped isolates, 30.3% were PCV13, 21.0% additional PCV20 and 48.7% non-PCV20 serotypes, yielding an estimated PCV20 coverage of 51.3%. All isolates were ceftriaxone-susceptible; penicillin resistance (4.6%) was limited to meningitis. Case fatality was 5.0%. In multivariable analysis, sepsis (adjusted odds ratio [aOR] 20.82; 95% CI: 4.23\u2013102.58) and meningitis (aOR 10.75; 95% CI: 2.10\u201354.95) were strongly associated with mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In the late PCV13 era, pediatric IPD in Argentina remains clinically severe and shows marked serotype replacement. PCV20 increases coverage to approximately half of circulating serotypes. Sepsis and meningitis remain key mortality determinants, underscoring the need for early recognition, timely treatment, improved vaccination coverage and continued surveillance to assess PCV20 impact.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005299","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:00:41Z","timestamp":1780459241000},"page":"1097-1102","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Invasive Pneumococcal Disease in Argentine Children After Widespread PCV13 Use: Burden, Potential PCV20 Coverage and Mortality Risk Factors Across Three Years of Surveillance"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1072-7700","authenticated-orcid":false,"given":"\u00c1ngela","family":"Gentile","sequence":"first","affiliation":[{"name":"Hospital de Ni\u00f1os Ricardo Gutierrez, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bakir","sequence":"additional","affiliation":[{"name":"Hospital de Ni\u00f1os Ricardo Gutierrez, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"L\u00f3pez Papucci","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Hospital de Ni\u00f1os V\u00edctor Vilela, Rosario, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Ensinck","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Hospital de Ni\u00f1os V\u00edctor Vilela, Rosario, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Ver\u00f3nica","family":"Firpo","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Hospital del Ni\u00f1o Jes\u00fas, Tucum\u00e1n, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Hospital Pedi\u00e1trico Fernando Barreyro, Posadas, Misiones, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Hospital Pedi\u00e1trico Fernando Barreyro, Posadas, Misiones, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena","family":"Ju\u00e1rez","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Hospital de Ni\u00f1os Pedro de Elizalde, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo Daniel","family":"Cancellara","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Hospital de Ni\u00f1os Pedro de Elizalde, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Natalia","family":"Pejito","sequence":"additional","affiliation":[{"name":"Hospital de Ni\u00f1os Ricardo Gutierrez, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Tapponnier","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Hospital Nacional Alejandro Posadas, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostina","family":"Tinnirello","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Hospital Nacional Alejandro Posadas, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"R1-20261110","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15.","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Global Health"},{"key":"R2-20261110","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"R3-20261110","doi-asserted-by":"crossref","first-page":"e0166736","DOI":"10.1371\/journal.pone.0166736","article-title":"Impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American countries: a systematic review.","volume":"11","author":"de Oliveira","year":"2016","journal-title":"PLoS One"},{"key":"R4-20261110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(20)30489-8","article-title":"SIREVA WorkingGroup. The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study.","volume":"21","author":"Agudelo","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"R7-20261110","first-page":"502","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of consolidated pneumonia in children younger than 5 years old in Pilar, Buenos Aires: a population-based study.","volume":"113","author":"Gentile","year":"2015","journal-title":"Arch Argent Pediatr"},{"key":"R8-20261110","doi-asserted-by":"crossref","first-page":"e0199989","DOI":"10.1371\/journal.pone.0199989","article-title":"PCV13 vaccination impact: a multicenter study of pneumonia in 10 pediatric hospitals in Argentina.","volume":"13","author":"Gentile","year":"2018","journal-title":"PLoS One"},{"issue":"suppl_1","key":"R9-20261110","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/ofid\/ofv133.1435","article-title":"Influence of respiratory viruses on the evaluation of 13-valent pneumococcal conjugate vaccine effectiveness in children under 5 years old: a time-series study 2001\u20132014.","volume":"2","author":"Gentile","year":"2015","journal-title":"Open Forum Infect Dise"},{"key":"R10-20261110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.vaccine.2021.12.008","article-title":"Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance.","volume":"40","author":"Zintgraff","year":"2022","journal-title":"Vaccine"},{"key":"R12-20261110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study.","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R13-20261110","doi-asserted-by":"crossref","first-page":"e0304978","DOI":"10.1371\/journal.pone.0304978","article-title":"Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis.","volume":"19","author":"Bardach","year":"2024","journal-title":"PLoS One"},{"key":"R14-20261110","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.vaccine.2019.12.038","article-title":"Invasive pneumococcal disease among hospitalized children in Brazil before and after the introduction of a pneumococcal conjugate vaccine.","volume":"38","author":"Berezin","year":"2020","journal-title":"Vaccine"},{"key":"R15-20261110","first-page":"100341","article-title":"Invasive pneumococcal disease and long-term outcomes in children: a 20-year population cohort study.","volume":"14","author":"Versluys","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"R16-20261110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.17843\/rpmesp.2025.421.14390","article-title":"Detection of Streptococcus pneumoniae in sterile liquids using real-time PCR (qPCR) in hospitalized patients with suspected invasive pneumococcal disease.","volume":"42","author":"Gonzales","year":"2025","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"R17-20261110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1473-3099(24)00588-7","article-title":"Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.","volume":"25","author":"Garcia Quesada","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"R18-20261110","doi-asserted-by":"crossref","first-page":"127031","DOI":"10.1016\/j.vaccine.2025.127031","article-title":"Distribution of pneumococcal serotypes causing invasive and non-invasive diseases in children in Mexico after introduction of PCV13 (2012-2023). Results from the GIVEBPVac group.","volume":"55","author":"Soto-Noguer\u00f3n","year":"2025","journal-title":"Vaccine"},{"key":"R20-20261110","doi-asserted-by":"crossref","first-page":"1337276","DOI":"10.3389\/fpubh.2024.1337276","article-title":"Antimicrobial resistance of Streptococcus pneumoniae from invasive pneumococcal diseases in Latin American countries: a systematic review and meta-analysis.","volume":"12","author":"Sandoval","year":"2024","journal-title":"Front Public Health"},{"key":"R21-20261110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/pedsos.2024-000284","article-title":"Temporal association between respiratory viruses and invasive streptococcal disease.","volume":"1","author":"Teoh","year":"2025","journal-title":"Pediatr Open Sci"},{"key":"R22-20261110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3192","article-title":"Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection.","volume":"122","author":"Ampofo","year":"2008","journal-title":"Pediatrics"},{"key":"R23-20261110","first-page":"100448","article-title":"Increase of invasive pneumococcal disease in children temporally associated with RSV outbreak in Quebec: a time-series analysis.","volume":"19","author":"Ouldali","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"R24-20261110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3201\/eid1901.120741","article-title":"Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.","volume":"19","author":"Ladhani","year":"2013","journal-title":"Emerg Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:01:27Z","timestamp":1794326487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005299","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"2025-12-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}